Article Information
History
- September 12, 2022.
Article Versions
- Version 1 (July 14, 2022 - 21:50).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Helsinki Institute of Life Science (HILIFE), University of Helsinki, 00014 Helsinki, Finland
- 2Faculty of Pharmacy, University of Helsinki, 00014 Helsinki, Finland
- 3Max Planck Institute for Biological Cybernetics, 72076 Tuebingen, Germany
- ↵*Corresponding author, Correspondence: nelson.totah{at}helsinki.fi